3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
12
Colonic Neoplasms
5
Pain, Postoperative
3
Liver Neoplasms
3
Stomach Neoplasms
2
Inflammatory Bowel Diseases
2
Diverticulitis
2
Agnosia
2
Recurrence
1
Rectal Neoplasms
1
Patient Satisfaction
1
Pancreatic Neoplasms
1
Pain
1
Neuropathy, Painful
1
Neuralgia
1
Neoplasm Metastasis
1
Inflammation
1
Ileus
1
Diverticulosis, Colonic
1
Diverticulitis, Colonic
1
Constipation
1
Cold Hypersensitivity
1
Carcinoma, Hepatocellular
1
Interventions
Oxaliplatin
10
Gemcitabine
8
Cisplatin
7
Hepatectomy
6
Fluorouracil
6
Radiofrequency Ablation
5
Liver Transplantation
5
Irinotecan
5
Capecitabine
5
lenvatinib
4
Paclitaxel
4
Neoadjuvant Therapy
4
Folfox protocol
4
Cetuximab
4
Aspirin
4
tislelizumab
3
Surgical Procedures, Operative
3
Nivolumab
3
Carboplatin
3
titanium silicide
2
durvalumab
2
apatinib
2
Trastuzumab
2
S 1 (combination)
2
Leucovorin
2
Lamivudine
2
Introns
2
Ethiodized Oil
2
Drug Therapy
2
DNA, Mitochondrial
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recurrence
×
Lidocaine
×
Gastrointestinal
×
Clear all
NCT05250791
2023-06-09
FLICOR
Imperial College London
Phase NA
Unknown
50 enrolled